Stephen K. Burley
Corporate Officer/Principal at The Rockefeller University
Stephen K. Burley active positions
| Companies | Position | Start | End |
|---|---|---|---|
| The Rockefeller University | Corporate Officer/Principal | 01/06/1997 | - |
Career history of Stephen K. Burley
Former positions of Stephen K. Burley
| Companies | Position | Start | End |
|---|---|---|---|
SGX Pharmaceuticals, Inc.
 SGX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SGX Pharmaceuticals, Inc. researches and develops drugs and other pharmaceutical products. The company was incorporated in June 20, 1999 and is headquartered in San Diego, CA. | Chief Tech/Sci/R&D Officer | 01/01/2002 | 18/04/2011 |
| CASCADIAN THERAPEUTICS INC (USA) | Director/Board Member | 09/06/2008 | 04/09/2008 |
Prospect Genomics, Inc.
 Prospect Genomics, Inc. Packaged SoftwareTechnology Services Prospect Genomics, Inc. developed computational technology solutions for the pharmaceutical field. The company was headquartered in San Diego, CA. | Founder | 21/12/2009 | - |
| Corporate Officer/Principal | - | 21/12/2009 |
Training of Stephen K. Burley
| Harvard University | Doctorate Degree |
| University of Oxford | Doctorate Degree |
| University of Western Ontario | Undergraduate Degree |
Statistics
International
| United States | 6 |
| United Kingdom | 2 |
| Canada | 2 |
Operational
| Doctorate Degree | 2 |
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoral
| Consumer Services | 5 |
| Health Technology | 3 |
| Technology Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 3 |
|---|---|
SGX Pharmaceuticals, Inc.
SGX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SGX Pharmaceuticals, Inc. researches and develops drugs and other pharmaceutical products. The company was incorporated in June 20, 1999 and is headquartered in San Diego, CA. | Health Technology |
Prospect Genomics, Inc.
Prospect Genomics, Inc. Packaged SoftwareTechnology Services Prospect Genomics, Inc. developed computational technology solutions for the pharmaceutical field. The company was headquartered in San Diego, CA. | Technology Services |
Cascadian Therapeutics LLC
 Cascadian Therapeutics LLC Medical SpecialtiesHealth Technology Cascadian Therapeutics LLC is a clinical-stage biopharmaceutical company, which focuses on the development of therapeutic products for the treatment of cancer. Its product ONT-380, is an orally active and selective small-molecule HER2 inhibitor. The firm also develops preclinical product candidates in oncology using Chk1 kinase inhibitor and protocell technology. The company was founded on September 7, 2007 and is headquartered in Bothell, WA. | Health Technology |
- Stock Market
- Insiders
- Stephen K. Burley
- Experience
